AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367 | -23.2% | 18,164 | -2.9% | 0.00% | -25.0% |
| Q2 2023 | $478 | -17.6% | 18,709 | -4.0% | 0.00% | -20.0% |
| Q1 2023 | $580 | +1.6% | 19,498 | -7.6% | 0.01% | 0.0% |
| Q4 2022 | $571 | -99.9% | 21,102 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $460,000 | -21.0% | 21,102 | -0.9% | 0.00% | -20.0% |
| Q2 2022 | $582,000 | -19.7% | 21,287 | -1.6% | 0.01% | -16.7% |
| Q1 2022 | $725,000 | -53.9% | 21,644 | -52.4% | 0.01% | 0.0% |
| Q4 2021 | $1,574,000 | +120.1% | 45,426 | +98.3% | 0.01% | 0.0% |
| Q3 2021 | $715,000 | -15.9% | 22,910 | -2.0% | 0.01% | -14.3% |
| Q2 2021 | $850,000 | +308.7% | 23,375 | +415.4% | 0.01% | -12.5% |
| Q4 2020 | $208,000 | 0.0% | 4,535 | -41.2% | 0.01% | +60.0% |
| Q1 2020 | $208,000 | -22.1% | 7,716 | -2.8% | 0.01% | 0.0% |
| Q4 2019 | $267,000 | -1.8% | 7,935 | +9.3% | 0.01% | -16.7% |
| Q3 2019 | $272,000 | -16.0% | 7,262 | -2.4% | 0.01% | -25.0% |
| Q2 2019 | $324,000 | +10.2% | 7,438 | +7.8% | 0.01% | +14.3% |
| Q1 2019 | $294,000 | -1.7% | 6,899 | +3.4% | 0.01% | -12.5% |
| Q4 2018 | $299,000 | -35.8% | 6,669 | -1.9% | 0.01% | -33.3% |
| Q3 2018 | $466,000 | – | 6,796 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |